ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 31 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,304,000 | +90.6% | 176,514 | 0.0% | 0.10% | +77.6% |
| Q2 2016 | $1,209,000 | -23.5% | 176,514 | +5.6% | 0.06% | -24.7% |
| Q1 2016 | $1,580,000 | -33.8% | 167,185 | -29.5% | 0.08% | -31.9% |
| Q4 2015 | $2,387,000 | +57.0% | 237,070 | +123.2% | 0.11% | +43.0% |
| Q3 2015 | $1,520,000 | – | 106,201 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 3,662,342 | $7,874,000 | 0.16% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 213,469 | $438,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 150,914 | $309,000 | 0.04% |
| Bernardo Wealth Planning LLC | 30,469 | $62,000 | 0.03% |
| Penserra Capital Management LLC | 351,154 | $719,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,900 | $361,000 | 0.01% |
| Founders Capital Management | 3,000 | $9,000 | 0.01% |
| King Wealth Management Group | 16,000 | $33,000 | 0.01% |
| Aquatic Capital Management LLC | 1,900 | $4,000 | 0.01% |
| Newbridge Financial Services Group, Inc. | 6,075 | $12,000 | 0.01% |